Pharmaceuticals, Biotechnology and Life Sciences
– Trial Did Not Meet Statistical Significance on Improvement in Primary Endpoints of Progression Free Survival (PFS) or Overall Survival…
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted…
SAN DIEGO and TORONTO, July 19, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision…
STI-1558, an oral SARS-CoV-2 main protease inhibitor which can block viral replication, is specifically designed as a standalone treatment of…
Idorsia will publish its half year financial results 2022 on Tuesday July 26, 2022, at 07:00 CEST. An investor conference…
KEY FIGURESRevenue in first half of 2022 -Provisional €616.4 millionGrowth at constant exchange rates and scope 1 +12.0% including companion animals +14.2%…
Dr. Drew to Raise Awareness of Petros Pharmaceuticals’ Mission in The Men’s Health Category and STENDRA® (avanafil) Dr. Drew Pinsky…
-Double-Blind, Randomized, Placebo-Controlled HOPE-3 Clinical Trial Designed to Enroll approximately 70 Patients- -HOPE-3 Builds on Positive Data Results from HOPE-2…
Initiates Fourth Cohort at a 650-Microgram Dose with Data Expected in Q4 2022SOLANA BEACH, Calif., July 19, 2022 (GLOBE NEWSWIRE)…
Peer-reviewed study highlights high potential for cell-penetrating peptides in mRNA-based cancer treatmentsDemonstrates effective uptake and transfection capacity of Altamira’s proprietary…